Sanofi India Ltd. saw a strong uptick in its stock price on Friday, rising 6.04% to ₹5,288.30, following the announcement of its Q4 financial results. The stock traded within a day range of ₹5,009.00 – ₹5,290.15, with a previous close of ₹4,986.85. The company’s market capitalization stands at ₹120.88 billion, with a P/E ratio of 26.30 and a dividend yield of 3.18%.
The company reported a 9.7% year-on-year (YoY) increase in revenue to ₹514.9 crore, compared to ₹469.2 crore in the same quarter last year. EBITDA grew 18.8% YoY to ₹118.3 crore, while operating margins improved to 23% from 21.2% in Q4 2023. However, net profit fell 33.7% YoY to ₹91.3 crore from ₹137.7 crore a year ago.
Sanofi India’s board has recommended a final dividend of ₹117 per equity share (₹10 face value), subject to approval at the upcoming Annual General Meeting.
The company continues to strengthen its presence in the cardiovascular (CV) and central nervous system (CNS) segments, leveraging recent partnerships to drive expansion.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. The author or Business Upturn is not liable for any losses arising from the use of this information.
